Myriad Genetics Inc. (MYGN)
NASDAQ · Healthcare
Myriad Genetics Inc. Shareholder Equity 2009–2025
Myriad Genetics Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Myriad Genetics Inc. shareholder equity as of December 31, 2025: 368.0M, a 47.51% decrease year-over-year.
- Myriad Genetics Inc. shareholder equity for 2025 were 368.0M, a 47.51% decrease from 2024.
- Myriad Genetics Inc. shareholder equity for 2024 were 701.1M, a 10.48% decrease from 2023.
- Myriad Genetics Inc. shareholder equity for 2023 were 783.2M, a 11.58% decrease from 2022.
- Myriad Genetics Inc. shareholder equity for 2022 were 885.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Myriad Genetics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $368 |
| 2024 | $701 |
| 2023 | $783 |
| 2022 | $886 |
| 2021 | $968 |
| 2020 | $881 |
| 2019 | $1,089 |
| 2018 | $966 |
| 2017 | $768 |
| 2016 | $740 |
| 2015 | $662 |
| 2014 | $719 |
| 2013 | $729 |
| 2012 | $636 |
| 2011 | $567 |
Myriad Genetics Inc. Shareholder Equity — FAQ
Myriad Genetics Inc. (MYGN) shareholder equity over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MYGN's shareholder equity history?
The chart and table above show Myriad Genetics Inc.'s shareholder equity by year and by quarter, including the growth rate.